Название продукции:Potassium thiocyanate

IUPAC Name:

CAS:333-20-0
Молекулярная формула:CKNS
Чистота:98%
Номер в каталоге:CM000375
Молекулярная масса:97.18

Упаковочная единица Доступно для заказа Цена ($) Количество
CM000375-500g 1-2 Weeks ŵȡ

Только для использования в НИОКР..

Форма запроса

   refresh    

Информация о продукции

Номер CAS:333-20-0
Молекулярная формула:CKNS
Точка плавления:-
Smiles-код:[S-]C#N.[K+]
Плотность:
Номер в каталоге:CM000375
Молекулярная масса:97.18
Точка кипения:
Номер Mdl:MFCD00011413
Хранение:

Column Infos

Crinecerfont
The New England Journal of Medicine publishes the primary CAHtalyst™ Adult Phase 3 study results of Crinecerfont for the treatment of congenital adrenal hyperplasia (CAH). Classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21OHD) is a rare genetic disorder, affected by a lack of cortisol and/or aldosterone. Corticotropin-releasing factor type 1 receptor (CRF1) antagonism is shown to clinically decrease ACTH production and adrenal androgen levels.
Neurocrine's Crinecerfont is an investigational, selective CRF1 antagonist being developed to reduce and control excess adrenocorticotropic hormone (ACTH) and adrenal androgens. The phase 3 study meets primary and important key secondary endpoints, including a significant reduction in androstenedione levels and lowering glucocorticoid dosing.